Showing results (81-90 of 262) with videos related to

Sort By:
Pageof 27
Annals of Hematology|June 20, 2024
Quality of life assessment in diffuse large B-cell lymphoma (DLBCL) in REFLECT: a prospective, non-interventional, multicenter, German study, assessing Sandoz rituximab in combination with CHOPBoris Kubuschok, Burkhard Otremba, Manfred Welslau, et al.
International Journal of Cancer|September 23, 2014
Gene expression profiling of peripheral blood mononuclear cells during treatment with a gene-modified allogeneic tumor cell vaccine in advanced renal cell cancer: tumor-induced immunosuppression and a possible role for NF-κBAnne Flörcken, Michael Grau, Annette Wolf, et al.
Hematological Oncology|March 15, 2026
Role of Radiotherapy in the Era of Novel Immune-Based Treatment Strategies for Multiple MyelomaTom Schlusemann, Evgenii Shumilov, Gabriele Reinartz, et al.
British Journal of Haematology|June 26, 2026
Response-adapted consolidation and salvage strategies in secondary central nervous system lymphoma: Insights from a multicentre cohortFarina Eigendorff, Fabian Görke, Vanja Zeremski, et al.
Molecular Cancer Therapeutics|October 21, 2020
Selective Vulnerability to Pyrimidine Starvation in Hematologic Malignancies Revealed by AG-636, a Novel Clinical-Stage Inhibitor of Dihydroorotate DehydrogenaseGabrielle McDonald, Victor Chubukov, John Coco, et al.
Nature Communications|July 6, 2022
Clinical relevance of molecular characteristics in Burkitt lymphoma differs according to ageBirgit Burkhardt, Ulf Michgehl, Jonas Rohde, et al.
Annals of Hematology|July 10, 2023
Pretransplant spleen volume and outcome after hematopoietic stem cell transplantation (HSCT) in patients with acute myeloid leukemia (AML)Alexander Pohlmann, Eva Bentgens, Christoph Schülke, et al.
Frontiers in Oncology|June 15, 2026
Health-related quality of life after autologous stem cell transplantation for multiple myeloma or lymphoma impacts professional activity- an analysis from two German tertiary care centersAnna Franziska Hamm, Ajelet Loesche, Christine Eisfeld, et al.
European Journal of Haematology|July 12, 2018
90 Y-ibritumomab-tiuxetan as a therapeutic alternative for follicular lymphoma (FL): A single-center experienceEva U Spukti, Lars Henning Schmidt, Arik Schulze, et al.
Cancer Research|August 5, 2016
Splenic Marginal Zone Granulocytes Acquire an Accentuated Neutrophil B-Cell Helper Phenotype in Chronic Lymphocytic LeukemiaMarcel Gätjen, Franziska Brand, Michael Grau, et al.
Pageof 27